Table 3.
PTSD (+) (n = 390) | PTSD (−) (n = 184) |
p value | |
---|---|---|---|
Age, years | 48±16 | 51±17 | 0.02* |
Gender, female/male | 240/150 | 109/75 | 0.3 |
WHOQOL-BREF | |||
Physical | 45.3±18 | 60.5±20 | 0.0001** |
Mental | 46.1±15 | 58.7±17 | 0.0001** |
Social | 42±20 | 51±24 | 0.0001** |
Environmental | 56±16 | 68±17 | 0.0001** |
IES-R | |||
Intrusion | 18.6±5 | 4.8±3 | 0.0001** |
Avoidance | 20.6±4 | 8.9±3 | 0.0001** |
Hyperarousal | 13.9±4 | 4.2±3 | 0.0001** |
Contact with COVID-19 patient, % | 29 | 12 | 0.0001** |
COVID-19 diagnosis, % | 19 | 9 | 0.002* |
Comorbid diseases, % | 47 | 44 | 0.2 |
DIT, % | 36 | 22 | 0.001* |
PTSD (+): IES-R ≥30, PTSD (−): IES-R <30; DIT, disruption of treatment; PTSD, posttraumatic stress disorder; WHOQOL-BREF, the World Health Organization Quality of Life short form; IES-R, Impact of Event Scale − Revised; COVID-19, coronavirus disease 2019.
p < 0.05.
p < 0.001.